Empowered Funds, LLC Celldex Therapeutics, Inc. Call Options Transaction History
Empowered Funds, LLC
- $6.75 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CLDX
# of Institutions
188Shares Held
69.3MCall Options Held
220KPut Options Held
310K-
Wellington Management Group LLP Boston, MA8.35MShares$168 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.5MShares$131 Million9.94% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$94.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$78.4 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$75.5 Million1.45% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $940M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...